Skip to main content

Table 12 Summary of outcome measures used according to ICS recommendations, need for surgery, side effects

From: Pelvic floor muscle training and adjunctive therapies for the treatment of stress urinary incontinence in women: a systematic review

Studies

C1

C2

C3

C4

C5

% subjects proceeding to surgery

No serious adverse events reported

Aksac (2003)

 

1

1

1

   

Arvonen (2001)

1

1

1

    

Balmforth (2004)

1

1

 

2

   

Berghmans (1996)

1

2

1

1

   

Bidmead (2002)

1

1

 

1

   

Bo (1999)

3

3

1

1

  

yes

Bo (2000)

   

1

   

Cammu & van Nylen (1998)

2

3

1

1

 

17

yes

Chen (1999)

 

2

1

   

yes

Dumoulin (1995)

1

1

1

    

Dumoulin (2004)

1

1

1

2

  

yes

Finkenhagen (1998)

1

      

Glavind (1996)

1

1

    

yes

Hay-Smith (2002)

1

2

     

Johnson (2001)

1

2

1

    

Knight (1998)

1

1

1

    

Miller (1998)

 

1

     

Morkved (2002)

2

2

1

1

 

4.3–6.3

yes

Pages (2001)

1

 

1

    

Parkkinen (2004)

1

1

1

  

10.5

yes

Pieber (1995)

1

    

0

 

Sung (2000)

1

      

Turkan (2005)

1

3

1

    

Wong (2001)

1

2

1

1

   
  1. ICS Outcome Measurement categories; C 1= patient symptoms: perception of cure/improvement; C 2 = quantification of symptoms (objective measures): pad use, diary of incontinent episodes, pad tests; C 3 = clinicians' measures (pelvic floor muscle measures); C 4 = quality of life measures; C 5 = socioeconomic measures, blank cells indicate no relevant report.